Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: A cytogenetic risk assessment

Lancet

Volumn 366, Issue 9480, 2005, Pages 123-128

  Caine, Allan ^a   Maltby, A Edna ^b   Parkin, C Anthony ^c   Waters, Jonathan J ^d   Crolla, John A ^e  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e SALISBURY DISTRICT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMNION FLUID ANALYSIS; ANEUPLOIDY; ARTICLE; CHORION VILLUS SAMPLING; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL PROTOCOL; DIAGNOSTIC TEST; DOWN SYNDROME; FETUS KARYOTYPING; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC RISK; HUMAN; PATIENT REFERRAL; PHENOTYPE; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RELIABILITY; RISK ASSESSMENT; TRISOMY 13; TRISOMY 18; TRISOMY 21; UNITED KINGDOM;

EID: 22244465516     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66790-6     Document Type: Article

References (23)

1. T Hassold, K Arnovitz, PA Jacobs, K May, D Robinson Trisomy in humans: incidence origin and etiology Curr Opin Genet Dev 3 1993 398 403
2. Haddow JE, Palomaki GE, Knight GJ Prenatal screening for Down's syndrome with use of maternal serum markers N Engl J Med 327 1992 588 593
3. Wald NJ, Kennard A, Hackshaw A, McGuire A Antenatal screening for Down's syndrome J Med Screen 4 1997 181 246
4. KH Nicolaides, G Azar, D Byrne, C Mansur, K Marks Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy BMJ 304 1992 867 869
5. Snijders RJM, P Noble, N Sebire, A Souka, KH Nicolaides UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation Lancet 352 1998 343 346
6. Wald NJ, Watt HC, Hackshaw AK Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters N Engl J Med 341 1999 461 467
7. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH Screening for chromosome abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience Br J Obstet Gynaecol 110 2003 281 286
8. GM Grimshaw, A Szczepura, M Hulten Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities Health Technol Assess 7 2003 1 146
9. BE Ward, SL Gersen, MP Carelli Rapid prenatal diagnosis of chromosomal aneuploidies by fluorescence in situ hybridization: clinical experience with 4,500 specimens Am J Hum Genet 52 1993 854 865
10. P Lewin, P Kleinfinger, A Bazin, H Mossafa, S Szpiro-Tapia Defining the efficiency of fluorescence in situ hybridization on uncultured amniocytes on a retrospective cohort of 27 407 prenatal diagnoses Prenat Diagn 20 2000 1 6
11. MA Hulten, S Dhanjal, B Pertl Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR Reproduction 126 2003 279 297
12. L Verma, F Macdonald, P Leedham, M McConachie, S Dhanjal, Hultén M Rapid and simple prenatal DNA diagnosis of Down's syndrome Lancet 352 1998 9 12
13. LJ Levett, S Liddle, R Meredith A large-scale evaluation of amnio-PCR for the rapid prenatal diagnosis of fetal trisomy Ultrasound Obstet Gynecol 17 2001 115 118
14. K Mann, C Donaghue, SP Fox, Z Docherty, C Ogilvie Strategies for rapid prenatal diagnosis of chromosome aneuploidy Eur J Hum Genet 12 2004 907 915
15. V Cirigliano, G Voglino, MP Canadas Rapid prenatal diagnosis of common chromosome aneuploidies by QF-PCR. Assessment on 18,000 consecutive clinical samples Mol Hum Reprod 10 2004 839 846
16. MI Evans, GP Henry, WA Miller International, collaborative assessment of 146,000 prenatal karyotypes: expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used Hum Reprod 14 1999 1213 1216
17. B Thilaganathan, S Sairam, T Ballard, C Peterson, R Meredith Effectiveness of prenatal chromosomal analysis using multicolor fluorescent in situ hybridisation Br J Obstet Gynaecol 107 2000 262 266
18. AT Thein, SA Abdel-Fattah, PM Kyle, PW Soothill An assessment of the use of interphase FISH with chromosome specific probes as an alternative to cytogenetics in prenatal diagnosis Prenat Diagn 20 2000 275 280
19. UK Department of Health Our Inheritance, our future: realising the potential of genetics in the NHS 2003 Stationery Office London
20. DK Kalousek, FJ Dill, T Pantzar, BC McGillivray, SL Yong, RD Wilson Confined chorionic mosaicism in prenatal diagnosis Hum Genet 77 1987 163 167
21. D Warburton De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis: clinical significance and distribution of breakpoints Am J Hum Genet 49 1991 995 1013
22. The Association of Clinical Cytogeneticists http://www.cytogenetics.org. uk/ (accessed June 2, 2005)
23. MS Watson, PD Buchannan, MM Cohen Technical and clinical assessment of fluorescence in situ hybridization: An ACMG/ASHG position statement. I Technical considerations Genet Med 2 2000 356 361